AXSM vs PEAK
Axsome Therapeutics Inc (AXSM) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
PEAK (PEAK) common stock.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
PEAK does not have a complete income-statement cache yet.
AXSM currently screens at market cap $11.96B.
Not investment advice. Open the AXSM and PEAK stock pages for the full models.
Not investment advice.